Treatment of pulmonary aspergilloma with itraconazole.
AUTOR(ES)
Campbell, J H
RESUMO
In a 12 month open study of itraconazole in pulmonary aspergilloma nine patients received oral itraconazole 200 mg daily for six months followed by further itraconazole or observation for a further six months. There was no change in the serum IgG specific for Aspergillus fumigatus (mean (SE) change -4% (10%)) or symptoms of chronic cough and haemoptysis. In two of the three patients who continued treatment beyond six months symptoms and radiographic appearances improved and a temporary reduction in A fumigatus specific IgG occurred in one patient. Further experience of the effects of longer treatment are needed before oral itraconazole can be recommended for aspergilloma.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1021040Documentos Relacionados
- Treatment of pulmonary aspergilloma with itraconazole.
- Chronic necrotising pulmonary aspergillosis treated with itraconazole.
- Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole.
- Adrenal response to corticotropin during therapy with itraconazole.
- Disseminated histoplasmosis in an AIDS patient treated with itraconazole.